Amedica Corp. is looking to raise $4.5 million through a public offering slated to close on Tuesday. The funding raise comes in the middle of the Salt Lake City-based company's bid to obtain clearance for its Valeo cancellous-structure ceramic cervical (C+Csc) implant. Amedica has been waiting for the FDA to green light the device for nearly two years now. (See Medical Device Daily, Feb. 13, 2015.)
SAN FRANCISCO IBM Watson Health was a star at this year's J.P. Morgan Healthcare conference, announcing a trio of deals with high profile players. The latest was with the U.S. FDA to work together to define a way for to exchange health data across a variety of technology platforms with an initial focus on oncology data.
SAN FRANCISCO Abbott Laboratories came off a blockbuster year in 2016 filled with acquisitions, divestitures and lawsuits. Executives of the company took to the podium during the 35th annual J.P. Morgan Healthcare conference to give a look back to last year and to provide a prelude of what lies ahead in 2017.